Can Estradiol and Ghrelin Play a Protective Role in Epithelial Ovarian Cancer Incidence in Postmenopausal Women?
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Archives of Medical Research
- Vol. 52 (3) , 324-331
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Kerman University of Medical Sciences (940641)
This publication has 43 references indexed in Scilit:
- Ghrelin inhibits ovarian epithelial carcinoma cell proliferation in vitroOncology Reports, 2013
- 17β-Oestradiol activates proteolysis and increases invasion through phosphatidylinositol 3-kinase pathway in human cervical cancer cellsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2012
- Estradiol-dependent regulation of angiopoietin expression in breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer riskThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- The Convergent Development of Molecular-Targeted Drugs for Cancer Treatment and PreventionClinical Cancer Research, 2007
- Patterns and Progress in Ovarian Cancer Over 14 YearsObstetrics & Gynecology, 2006
- Novak's Gynecology, 13th EditionJournal of Midwifery & Women's Health, 2003
- Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKTJournal of Cell Biology, 2002
- Transvaginal ultrasonography assessment of ovarian volumes in postmenopausal womenSao Paulo Medical Journal, 1996
- Plasma level of estradiol in patients with ovarian malignant tumorsGynecologic Oncology, 1988